Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
25 studies found for:    bascom palmer eye institute | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy
Condition: Leber's Hereditary Optic Neuropathy
Interventions: Drug: injection of scAAV2-P1ND4v2 5.00x10e9 vg (Low),;   Drug: injection of scAAV2-P1ND4v2 2.46X10e10 vg (Med);   Drug: injection of scAAV2-P1ND4v2 1.0X10e11vg (High)
2 Not yet recruiting AvenovaTM as a Sterile Skin Preparation Agent
Condition: Cleaning Product Causing Toxic Effect
Interventions: Drug: Avenova;   Drug: Povidone-iodine 5% solution;   Drug: 4% chlorhexidine;   Drug: Isopropyl alcohol
3 Not yet recruiting Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
Condition: Diabetes
Intervention: Biological: Human Pancreatic Islet Transplantation
4 Recruiting Biomechanics of Optic Neuropathy
Condition: Optic Neuropathy
Intervention: Device: magnetic resonance image (MRI)
5 Recruiting A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Conditions: Corneal Neovascularization;   Corneal Graft Failure
Interventions: Drug: Avastin® (bevacizumab);   Drug: 0.9% NaCl & Refresh Liquigel
6 Recruiting Stop Retinal Ganglion Cell Dysfunction Study
Condition: Glaucoma
Interventions: Drug: Latanoprost;   Drug: Bimatoprost;   Drug: Travoprost;   Drug: Timolol;   Drug: Dorzolamide;   Drug: Brinzolamide;   Drug: Acetazolamide;   Drug: Methazolamide
7 Not yet recruiting The Role of Antioxidant Supplementation in Keratoconus Patients
Condition: Keratoconus
Interventions: Other: Antioxidants (Vitamins A,C,E) plus GSH;   Other: Placebo;   Dietary Supplement: Centrum;   Other: Dietary Sources
8 Recruiting Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Tear Deficient Dry Eye Disease.
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
9 Recruiting InnFocus MicroShunt Versus Trabeculectomy Study
Condition: Primary Open Angle Glaucoma
Interventions: Procedure: Glaucoma Surgery;   Device: InnFocus MicroShunt
10 Recruiting Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration
Conditions: Macular Degeneration;   Retinal Drusen
Interventions: Device: macular laser treatment;   Device: sham macular laser treatment
11 Recruiting Trial of AEB071 in Combination With BYL719 in Patients With Melanoma
Condition: Uveal Melanoma
Interventions: Drug: AEB071;   Drug: BYL719
12 Recruiting Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia
Condition: Achromatopsia
Intervention: Biological: rAAV2tYF-PR1.7-hCNGB3
13 Recruiting Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency
Condition: Convergence Insufficiency
Intervention: Procedure: Office-based vergence/accommodative therapy
14 Not yet recruiting Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia
Condition: Achromatopsia
Intervention: Biological: AGTC-402
15 Recruiting An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima A).
Condition: Geographic Atrophy
Intervention: Other: No intervention
16 Recruiting Treatment for CI-DME in Eyes With Very Good VA Study
Condition: Diabetic Macular Edema
Interventions: Procedure: Prompt Laser;   Drug: Prompt aflibercept;   Procedure: Deferred laser;   Drug: Deferred aflibercept
17 Recruiting Anti-VEGF Treatment for Prevention of PDR/DME
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Procedure: Prompt Sham;   Drug: Prompt aflibercept;   Procedure: Deferred laser;   Drug: Deferred aflibercept
18 Recruiting Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Condition: Keratolysis
Interventions: Drug: Riboflavin;   Drug: Dextran;   Device: UVA Light Source
19 Recruiting Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma, Open-Angle;   Ocular Hypertension
Interventions: Drug: Bimatoprost sustained-release;   Other: Sham;   Drug: Timolol;   Drug: Timolol Vehicle (placebo)
20 Recruiting Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 Neurotrophic Keratitis
Condition: Neurotrophic Keratitis
Interventions: Drug: rhNGF 20µg/ml;   Drug: Placebo Vehicle

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.